Ustekinumab, an antibody usually used to treat psoriasis can now decrease aortic inflammation finds a new study. This aortic inflammation is one of the key markers of major cardiovascular disease. The study found that patients who took the drug ustekinumab had a 19 percent improvement in aortic inflammation, as measured and confirmed by imaging, when compared to the placebo group.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer